By

Kelyniam
Kelyniam Global, Inc., (KLYG), a maker of patient specific craniofacial and skull implants, announced the submission of its third 510(k) application to the FDA to expand their line of custom implants. “The 510(k) submission is the result of our significant investments in research and development and in the quality infrastructure to successfully pursue regulatory applications,”...
Read More
Kelyniam Global (KLYG), a maker of custom cranial implants, announced the acquisition of new additive manufacturing technology to increase current medical modeling capabilities. “This state-of-the-art equipment will enable Kelyniam to produce certain medical models on the same 24-hour turnaround schedule we offer for cranial implants,” said Chris Breault, Kelyniam’s Chief Operating Officer.  “The ability to rapidly...
Read More
Kelyniam Global (KLYG), a maker of custom cranial implants, today reported financial results for the first two quarters of 2018. Highlights Revenue increased 45% over the same period last year, growing to $1,118,512 Gross profit grew 44% to $652,790 Net income declined to a loss of $29,847 due to significant investments in sales, marketing and...
Read More
COLLINSVILLE, CT–(June 1, 2018) – Kelyniam Global, Inc., (OTC: KLYG), a manufacturer of custom cranial implants has issued a letter to shareholders and published financials for 2015, 2016 and 2017. In the letter, Chairman and CEO Ross Bjella stated: Revenue grew 21%, to $1.85M, the highest revenues since 2013 2018 revenues are expected to grow...
Read More
Dear Shareholder, 2017 marks the first year since 2014 that the company has published financial information. You can now find financial information for 2015 and 2016 on our website, Kelyniam.com. Reporting financial information is just one example of the many positive changes happening at Kelyniam. I am pleased to report that year over year revenues...
Read More
CANTON, CT >> Kelyniam Global (KLYG), a maker of custom cranial implants, announced today that it has signed a multi-year distribution agreement with a leading medical device distributor in the neuroscience market. Dr. Mark Smith, Kelyniam’s Vice President of Sales said, “This agreement is in alignment with our sales strategy of building long-term relationships with...
Read More
CANTON, CT >> Kelyniam Global (KLYG), a maker of custom cranial implants, announced today that it has hired Ross Bjella as Chairman and Chief Executive Officer. The company had recently appointed Chris Breault as Chief Operating Officer after the former President, Tennyson Anthony, left the company in April of this year. The company has also...
Read More
1 2

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.

Recent Works

Recent Comments

    Tag Cloud